Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cresco Labs Inc (OP:CRLBF)

0.7162 -0.0637 (-8.17%)
Streaming Delayed Price Updated: 2:16 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cresco Labs Inc

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
420 with CNW — Divisive Colorado Cannabis Potency Bill Withdrawn at Committee Stage
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
420 with CNW — Divisive Colorado Cannabis Potency Bill Withdrawn at Committee Stage
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For March 18, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For March 14, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Week In Cannabis: Earnings, Europe's Buzzing Scene, The UN And More
Cannabis news this week: California extends hemp ban, UN schedules HHC, major earnings reports & Tilray expands. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 13, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Firm Cresco Labs Reports Mixed Q4, CEO Says Company Will 'Strategically Deploy Capital To Create Growth' In 2025
Cresco Labs posts Q4 revenue of $175.91M, beating estimates. The company secured a Tier 3 cultivation license in Kentucky, expanding its market presence. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cresco Labs’ Disciplined Strategy Drives Record Cash Flow in 2024 Financial Results
From Cresco Labs
Via Business Wire
Cannabis Stock Movers For March 10, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cresco Labs to Operate Kentucky’s Largest Medical Cannabis Cultivation License
From Cresco Labs
Via Business Wire
Ohio GOP Claims Voters Weren’t Informed While Approving Recreational Cannabis
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Ohio GOP Claims Voters Weren’t Informed While Approving Recreational Cannabis
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Cresco Labs to Report Fourth Quarter 2024 Financial Results on March 12, 2025
From Cresco Labs
Via Business Wire
Michigan to Distribute Almost $100m from Cannabis Taxes to Communities
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Michigan to Distribute Almost $100m from Cannabis Taxes to Communities
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Prohibitionists,  2 American Senators Work to Block 280E Relief for Marijuana Companies
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Missouri Courts Close to Completing Review of Marijuana Expungements
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
California Data Breach Compromises 380,000 Customers’ Data
Via CannabisNewsWire
Topics Cannabis Data Breach
Exposures Cannabis Information Security
'President Trump's Endorsement Represents A Sea Change In Cannabis Policy,' Says Trulieve CEO As Advocacy Groups Join Forces
"Our new combined organization will best position the industry to help the President get them over the finish line," says Trulieve CEO Kim Rivers. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Medical Cannabis Patients in Arkansas Reach Record Numbers
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For January 9, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
420 with CNW — Could the Growing Popularity of THC Drinks Push Alcohol Out of the US Market?
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — New Lawsuit Aims to Invalidate Nebraska’s Medical Marijuana Ballot Measures
Via CannabisNewsWire
Topics Cannabis Lawsuit
Exposures Cannabis Financial Legal
The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns
New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
420 with CNW — Study: Utah’s Medical Cannabis Legalization Lowered Opioid Use by Patients with Chronic Pain
Via CannabisNewsWire
Topics Cannabis Death
Exposures Cannabis Death
Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip
ollowing a drop in September cannabis sales numbers in Illinois, October figures totaled $142.3 million, a 4.2% increase sequentially, reported New Cannabis Ventures' Alan Brochstein. Cannabis sales... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.